Incyte (INCY) Current Leases (2018 - 2026)
Incyte (INCY) reported Current Leases of $4.4 million for Q1 2026, down 1.45% on a YoY basis from $4.5 million in Q1 2025, and down 2.28% quarter-over-quarter from $4.5 million in Q4 2025.
Incyte (INCY) Current Leases (2018 - 2026) Analysis & Trends
Incyte has reported Current Leases for 9 years, with the latest figure at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 1.45% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 1.45% YoY), and the FY2025 full-year result was $4.5 million, up 2.2% from the prior year.
- Current Leases for Q1 2026 stood at $4.4 million, down from $4.5 million in the prior quarter.
- The five-year high for Current Leases was $4.5 million in Q4 2025, with the low at $2.8 million in Q1 2022.
- Historically, Current Leases has averaged $3.7 million across 5 years, with a median of $3.7 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases plunged 76.02% — and 2024, when it increased 28.5%.
- Incyte's Current Leases stood at $3.2 million in 2022, then advanced by 8.18% to $3.4 million in 2023, then advanced by 28.5% to $4.4 million in 2024, then grew by 2.2% to $4.5 million in 2025, then declined by 2.28% to $4.4 million in 2026.
- The last three Current Leases figures came in at $4.4 million (Q1 2026), $4.5 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.41 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.93 Mn |
| Jun 30, 2024 | 3.87 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 9.85 Mn |
| Jun 30, 2021 | 2.41 Mn |